Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gratisovir versus Grateziano plus ribavirin for chronic hepatitis C genotype 4
ACTRN12615001111561Phase 4Recruiting
- Sponsor
- Green Clinic and Research Center
- Start
- Jun 2015
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of ribavirin in hepatitis C virus infection, sponsored by Green Clinic and Research Center. Primary endpoints: Sustained virologic response, Very rapid virologic response and 1 more. Started Jun 2015; status: recruiting.
02
Drugs
ribavirin
03
Conditions
hepatitis C virus infection
Beyond the preview
Go deeper on ACTRN12615001111561.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12615001111561.